INVIVA® | Discover the Advantages of IVIVA Specialty Clinics for Personalized Healthcare. - Inviva
A Unique Network of Care
Offering unparalleled services to patients and healthcare providers.
A Unique Network of Care
Offering unparalleled services to patients and healthcare providers.
A Specialized Care Team at Your Service
Our 300+ Registered Nurses have extensive experience in administering specialty and biologic drugs intravenously, subcutaneously, and intramuscularly. They provide seamless care for individuals—including pediatric patients— with complex diseases and conditions, managing various therapeutic areas such as oncology, gastroenterology, rheumatology, neurology and rare diseases.
With a keen focus on both patient safety and experience, our INVIVA nurses are trained in PALS (Pediatric Advanced Life Support), in addition to having a De Souza designation, a leading certification in cancer care.
Patient care coordinators and facility staff round out the INVIVA care team dedicated to providing patients with the best care possible.
A Specialized Care Team at Your Service
Our 300+ Registered Nurses have extensive experience in administering specialty and biologic drugs intravenously, subcutaneously, and intramuscularly. They provide seamless care for individuals—including pediatric patients— with complex diseases and conditions, managing various therapeutic areas such as oncology, gastroenterology, rheumatology, neurology and rare diseases.
With a keen focus on both patient safety and experience, our INVIVA nurses are trained in PALS (Pediatric Advanced Life Support), in addition to having a De Souza designation, a leading certification in cancer care.
Patient care coordinators and facility staff round out the INVIVA care team dedicated to providing patients with the best care possible.
The first accredited private infusion network in Canada
At INVIVA, we strive to make cutting-edge oncology services more accessible for patients outside the hospital setting. In 2023, our network established new standards of excellence for oncology in community infusion clinics. After meeting the requirements of the Qmentum accreditation program from Accreditation Canada, we became the first private network of infusion clinics accredited in oncology in Canada. The accreditation for cancer treatment subjects INVIVA to the same accreditation process used by hospitals that use Accreditation Canada to evaluate standards of excellence in quality, safety, and care.
In addition to receiving oncology accreditation, all our INVIVA clinics have been accredited in home care, outpatient care, medication management, infection prevention and control, and leadership standards.
Read our press release
The first accredited private infusion network in Canada
At INVIVA, we strive to make cutting-edge oncology services more accessible for patients outside the hospital setting. In 2023, our network established new standards of excellence for oncology in community infusion clinics. After meeting the requirements of the Qmentum accreditation program from Accreditation Canada, we became the first private network of infusion clinics accredited in oncology in Canada. The accreditation for cancer treatment subjects INVIVA to the same accreditation process used by hospitals that use Accreditation Canada to evaluate standards of excellence in quality, safety, and care.
In addition to receiving oncology accreditation, all our INVIVA clinics have been accredited in home care, outpatient care, medication management, infection prevention and control, and leadership standards.
Read our press release
A McKesson Canada Company
INVIVA’s parent company, McKesson Canada, is a diversified healthcare services leader dedicated to advancing health outcomes for patients for more than 100 years.
McKesson partners with pharmaceutical companies, care providers, pharmacies, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable.
INVIVA leverages McKesson’s network to access technology, drug supply distribution, best practices, evidence-based guidelines and quality measurements, in order to achieve patient satisfaction and operational excellence.
McKesson partners with manufacturers to bring new medications to market and provides INVIVA patients with access to specialized pharmaceutical treatments and patient counselling.
McKesson Canada’s Biopharma and Provider Solutions (BPS) team makes specialty medications more accessible by simplifying the complicated path that the specialty prescription travels before it gets to patients who are depending on it.
Many diseases treated with infusion therapy, including rheumatoid arthritis, Crohn’s Disease, ulcerative colitis, multiple sclerosis, Alzheimer’s Disease and cancer, require specialty medications.
A specialty medication is a drug that requires either specialized manufacturing, distribution or administration, or close monitoring. Getting a specialty medication prescription filled is more complicated and can take longer to process than a regular prescription.